Azhimamatova Rakhima Momunovna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Azhimamatova Rakhima Momunovna has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Mohd Faizan Siddiqui
International Medical Faculty, Osh State University, Osh City, Kyrgyzstan
2 shared publications - Abdirasulova Zhainagul Abdirasulovna
Osh State University, International Medical Faculty
1 shared publication Anja Stajnko
Jožef Stefan Institute, Ljubljana, Slovenia
1 shared publicationDarja Mazej
Jožef Stefan Institute, Ljubljana, Slovenia
1 shared publication- Evgenij K. Beltyukov
Ural State Medical University
1 shared publication - Fakher Rahim
Osh State University
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 11 (1)
Integration of Deep Learning and Mendelian Randomization Identifies Causal Biomarkers for CHD
- 1 January 2026
- Published by Compuscript, Ltd. in Cardiovascular Innovations and Applications
- Vol. 11 (1)
Open AccessIntegration of Deep Learning and Mendelian Randomization Identifies Causal Biomarkers for CHD
- Open Access
- 20 June 2025
- Published by Elsevier in Environmental Research
- Vol. 284, 122204
Blood metal(loid)s, haemoglobin and goitre in pregnant women from the mercury-exposed and non-exposed environment (Aidarken area vs Kara-Suu area; Kyrgyz Republic)
- 20 June 2025
- Published by Elsevier in Environmental Research
- Vol. 284, 122204
Open AccessBlood metal(loid)s, haemoglobin and goitre in pregnant women from the mercury-exposed and non-exposed environment (Aidarken area vs Kara-Suu area; Kyrgyz Republic)
- Open Access
- 9 December 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 202-209
Lung diseases in adult patients with primary immunodeficiencies with defects of antibody production according to real clinical practice
Introduction. The problem of lung diseases in patients with primary defects in antibody production has not been sufficiently studied, especially depending on the climatic, geographical and demographic conditions of real clinical practice.Aim. To study the structure of lung disorders in adult patients with primary antibodies defects in the Middle Urals in real clinical practice.Materials and methods. Register of adult patients with primary immunodeficiencies (PID) were created in 2013 in the Sverdlovsk region. Now it contains 209 people. The main group of the register is patients with primary antibodies defects (PAD, n = 143, 68.4%: agammaglobulinemia (AGG, n = 11, common variable immune deficiency (CVID, n = 37), PIK3-Kinase deficiency (n = 3), Selective IgA deficiency (SD IgA, n = 92). The diagnosis of PID was established on the criteria for the Russian Association of Allergists and Clinical Immunologists and European Societies of Immunodeficencies, in some cases it has a genetic confirmation. We used medical history of patients, radiological, functional studies to establish lung lesions. We occurred immunological examination for all PID patients.Results. Repeated pneumonia were observed in all patients with AGG and CVID, especially in the onset of PID. Patients also had diseases such as bronchiectasis (up to 37.6% of patients), chronic obstructive lung disease (up to 70.3% of patients), bronchial asthma (only SD IgA), interstitial lung disease (only CVID).Conclusion. According to our data, in the Middle Urals, lung diseases, especially pneumonia and bronchiectasis, are the most common clinical manifestations in patients with DA. Analysis of immunoglobulins' level is necessary in patients with repeated pneumonia, bronchiectasis and interstitial lung disease, bronchial asthma and early onset of chronic obstructive lung disease without smoking status.
- 9 December 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 202-209
Open AccessLung diseases in adult patients with primary immunodeficiencies with defects of antibody production according to real clinical practice
Introduction. The problem of lung diseases in patients with primary defects in antibody production has not been sufficiently studied, especially depending on the climatic, geographical and demographic conditions of real clinical practice.Aim. To study the structure of lung disorders in adult patients with primary antibodies defects in the Middle Urals in real clinical practice.Materials and methods. Register of adult patients with primary immunodeficiencies (PID) were created in 2013 in the Sverdlovsk region. Now it contains 209 people. The main group of the register is patients with primary antibodies defects (PAD, n = 143, 68.4%: agammaglobulinemia (AGG, n = 11, common variable immune deficiency (CVID, n = 37), PIK3-Kinase deficiency (n = 3), Selective IgA deficiency (SD IgA, n = 92). The diagnosis of PID was established on the criteria for the Russian Association of Allergists and Clinical Immunologists and European Societies of Immunodeficencies, in some cases it has a genetic confirmation. We used medical history of patients, radiological, functional studies to establish lung lesions. We occurred immunological examination for all PID patients.Results. Repeated pneumonia were observed in all patients with AGG and CVID, especially in the onset of PID. Patients also had diseases such as bronchiectasis (up to 37.6% of patients), chronic obstructive lung disease (up to 70.3% of patients), bronchial asthma (only SD IgA), interstitial lung disease (only CVID).Conclusion. According to our data, in the Middle Urals, lung diseases, especially pneumonia and bronchiectasis, are the most common clinical manifestations in patients with DA. Analysis of immunoglobulins' level is necessary in patients with repeated pneumonia, bronchiectasis and interstitial lung disease, bronchial asthma and early onset of chronic obstructive lung disease without smoking status.
- 1 August 2022
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 18 (3) , 179-189
The Spectrum of Airway Disease Associated with Rheumatoid Arthritis
Airway involvement results from long-standing rheumatoid arthritis leading to severe pulmonary complications, correlated with increased mortality and socioeconomic costs. Different types of pulmonary lesions, including pulmonary rheumatoid nodule, pulmonary arteritis, diffuse interstitial fibrosis, and rheumatoid pneumoconiosis or Caplan's syndrome, are believed to be relat-ed to rheumatoid arthritis (R.A.). The above changes may indicate the increased susceptibility to the infection, toxins from a disease, or chronic immunity activation. The symptoms vary from asymp-tomatic to severe life-treating conditions, and the prognosis varies depending on the genre and se-verity of involvement. Our study aims to assess the prevalence and characteristics of airways asso-ciation in rheumatoid arthritis as these data provide a brief insight into early diagnosis and treat-ment, which could be applied to minimize complications of airways diseases in rheumatoid arthritis.
- 1 August 2022
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 18 (3) , 179-189
The Spectrum of Airway Disease Associated with Rheumatoid Arthritis
Airway involvement results from long-standing rheumatoid arthritis leading to severe pulmonary complications, correlated with increased mortality and socioeconomic costs. Different types of pulmonary lesions, including pulmonary rheumatoid nodule, pulmonary arteritis, diffuse interstitial fibrosis, and rheumatoid pneumoconiosis or Caplan's syndrome, are believed to be relat-ed to rheumatoid arthritis (R.A.). The above changes may indicate the increased susceptibility to the infection, toxins from a disease, or chronic immunity activation. The symptoms vary from asymp-tomatic to severe life-treating conditions, and the prognosis varies depending on the genre and se-verity of involvement. Our study aims to assess the prevalence and characteristics of airways asso-ciation in rheumatoid arthritis as these data provide a brief insight into early diagnosis and treat-ment, which could be applied to minimize complications of airways diseases in rheumatoid arthritis.